Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1999 Oct 12;9621:12162-7. doi: 10.1073/pnas.96.21.12162.
Show Gene links
Show Anatomy links
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP.
D'hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, Vivaudou M.
???displayArticle.abstract???
The pharmacological phenotype of ATP-sensitive potassium (K(ATP)) channels is defined by their tissue-specific regulatory subunit, the sulfonylurea receptor (SUR), which associates with the pore-forming channel core, Kir6.2. The potassium channel opener diazoxide has hyperglycemic and hypotensive properties that stem from its ability to open K(ATP) channels in pancreas and smooth muscle. Diazoxide is believed not to have any significant action on cardiac sarcolemmal K(ATP) channels. Yet, diazoxide can be cardioprotective in ischemia and has been found to bind to the presumed cardiac sarcolemmal K(ATP) channel-regulatory subunit, SUR2A. Here, in excised patches, diazoxide (300 microM) activated pancreatic SUR1/Kir6.2 currents and had little effect on native or recombinant cardiac SUR2A/Kir6.2 currents. However, in the presence of cytoplasmic ADP (100 microM), SUR2A/Kir6.2 channels became as sensitive to diazoxide as SUR1/Kir6. 2 channels. This effect involved specific interactions between MgADP and SUR, as it required Mg(2+), but not ATP, and was abolished by point mutations in the second nucleotide-binding domain of SUR, which impaired channel activation by MgADP. At the whole-cell level, in cardiomyocytes treated with oligomycin to block mitochondrial function, diazoxide could also activate K(ATP) currents only after cytosolic ADP had been raised by a creatine kinase inhibitor. Thus, ADP serves as a cofactor to define the responsiveness of cardiac K(ATP) channels toward diazoxide. The present demonstration of a pharmacological plasticity of K(ATP) channels identifies a mechanism for the control of channel activity in cardiac cells depending on the cellular ADP levels, which are elevated under ischemia.
Aguilar-Bryan,
Toward understanding the assembly and structure of KATP channels.
1998, Pubmed
Aguilar-Bryan,
Toward understanding the assembly and structure of KATP channels.
1998,
Pubmed Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed Alekseev,
Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening.
1998,
Pubmed Babenko,
Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
1998,
Pubmed Brady,
Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas.
1998,
Pubmed Ciampolillo,
Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
1992,
Pubmed D'hahan,
A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
1999,
Pubmed
,
Xenbase Dzeja,
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.
1999,
Pubmed Dzeja,
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels.
1998,
Pubmed Faivre,
Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle.
1989,
Pubmed Forestier,
Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons.
1996,
Pubmed Garlid,
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
1997,
Pubmed Gribble,
The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
1997,
Pubmed
,
Xenbase Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed Higgins,
ABC transporters: from microorganisms to man.
1992,
Pubmed Holmuhamedov,
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria.
1999,
Pubmed Holmuhamedov,
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function.
1998,
Pubmed Hung,
Crystal structure of the ATP-binding subunit of an ABC transporter.
1998,
Pubmed Inagaki,
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
1995,
Pubmed Inagaki,
A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.
1996,
Pubmed Isomoto,
A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel.
1996,
Pubmed Isomoto,
Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system.
1997,
Pubmed Jahangir,
Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes.
1994,
Pubmed Jovanovic,
Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate.
1996,
Pubmed Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase Liu,
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
1998,
Pubmed Lorenz,
Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A.
1999,
Pubmed Lorenz,
Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel.
1998,
Pubmed Okuyama,
The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells.
1998,
Pubmed Paulissian,
Diazoxide.
1978,
Pubmed Radda,
The use of NMR spectroscopy for the understanding of disease.
1986,
Pubmed Sato,
Cibenzoline inhibits diazoxide- and 2,4-dinitrophenol-activated ATP-sensitive K+ channels in guinea-pig ventricular cells.
1993,
Pubmed Schwanstecher,
Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
1998,
Pubmed Seino,
ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies.
1999,
Pubmed Shyng,
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
1997,
Pubmed Standen,
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.
1989,
Pubmed Terzic,
Dualistic behavior of ATP-sensitive K+ channels toward intracellular nucleoside diphosphates.
1994,
Pubmed Trube,
Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.
1986,
Pubmed Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase Ueda,
MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
1997,
Pubmed Venkatesh,
Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle.
1991,
Pubmed Vivaudou,
Modification by protons of frog skeletal muscle KATP channels: effects on ion conduction and nucleotide inhibition.
1995,
Pubmed
